The Week in Review: March 4-8

From an update on Prism for PTSD to the efficacy of home-use transcranial direct current stimulation for MDD, here are highlights from the week in Psychiatric Times.

Related Keywords

California ,United States ,San Diego ,David Feifel ,Graymatters Health Ltd ,University Of California ,Drug Administration ,Kadima Neuropsychiatry Institute ,Psychiatric Times ,Breakthrough Designation ,Generalized Anxiety ,Use Transcranial Direct Current Stimulation ,Major Depressive ,Highlights Efficacy ,Alleviating Chronic ,Graymatters Health ,Cumulative Remission Rate ,Why It Still ,Psychiatric Timesarticle ,